The pharmacokinetics, safety, and tolerance of cefepime administered as an intravenous bolus or as a rapid infusion

Annals of Pharmacotherapy

Volumn 33, Issue 12, 1999, Pages 1258-1261

  Garrelts, James C ^a   Wagner, David J ^b  

^a Clinical Pharmacy Services   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

Cefepime; Intravenous bolus; Pharmacokinetics

Indexed keywords

CEFEPIME;

ADULT; AREA UNDER THE CURVE; ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG INFUSION; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0033390528     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.19067     Document Type: Article

References (21)

1. Sullivan V, Koch KE. Development of iv push guidelines. Am J Hosp Pharm 1992;49:2427-33.
2. Wood WW, Miano BL. Implementation of an iv push method of administration using the focus/PDCA approach (abstract). American Society of Hospital Pharmacists Home Care Meeting, Atlanta, GA, December 7-11, 1997;4:11.
3. Robinson KD, Herrington AM, Woodward BW. Cost-effectiveness of administering iv push antibiotics (abstract). American Society of Hospital Pharmacists Midyear Clinical Meeting, Atlanta, GA, December 7-11, 1997;32:127E.
4. Kreitman TM, Grass CA. IV push antibiotics: alternative method of drug administration (abstract). American Society of Hospital Pharmacists Midyear Clinical Meeting, Atlanta, GA, December 7-11, 1995;30:528(D).
5. Garrelts JC, Ast D, Larocca J, Smith DF Jr, Peterie JD. Postinfusion phlebitis after intravenous push versus intravenous piggyback administration of antimicrobial agents. Clin Pharm 1988;7:760-5.
6. Garrelts JC, Smith DF, Ast D, Peterie JD. A comparison of the safety, timing, and cost-effectiveness of administering antibiotics by intravenous bolus (push) versus intravenous piggyback (slow infusion) in surgical prophylaxis. Pharmacoeconomics 1992;1:116-23.
7. Cost effectiveness of administering iv push antibiotics. Formulary 1998; 33:595.
8. Ambrose PG, Quintiliani R, Nightingale CH. Pharmacoeconomic analysis of administration of famotidine iv push vs. intermittent slow iv infusion (letter). Ann Pharmacother 1997;31:645.
9. Markowsky SJ, Santeiro ML. Automatic therapeutic substitution: cost savings with intravenous push famotidine (letter). Ann Pharmacother 1995;29:316.
10. Nowobilski-Vasilios A, Markel SK. IV push antibiotics: preliminary report of home care outcomes. Presented at the American Society of Hospital Pharmacists Home Care Meeting, Atlanta, GA, December 7-11, 1997;4:11.
11. Skambaram A, Madhavan T, Meyette E. Efficacy, safety and cost effectiveness of cefepime in an outpatient iv infusion therapy program (OP-TIVIT). Home Healthcare Consultant 1998;5(suppl B):1-5.
12. Barbhaiya RH, Forgue ST, Shyu WC, Papp EA, Pittman KA. High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine. Antimicrob Agents Chemother 1987;31:55-9.
13. SAS/STAT user's guide, VCR 5.16. Cary, NC: SAS, 1988.
14. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker, Inc., 1982:409-17.
15. Snedecor GW, Cochran WG. Statistical methods. 6th ed. Ames, IA: Iowa State University Press, 1973:135-71.
16. Riegelman S, Collier P. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm 1980;8:509-34.
17. Barbhaiya RH, Forgue ST, Gleason CR, Knupp CA, Pittman KA, Weidler DJ, et al. Safety, tolerance and pharmacokinetic evaluation of cefepime after administration of single intravenous doses. Antimicrob Agents Chemother 1990;34:1118-22.
18. Barbhaiya RH, Forgue ST, Gleason CR, Knupp CA, Pittman KA, Weidler DJ, et al. Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects. Antimicrob Agents Chemother 1992;36:552-7.
19. Stewart JT, Warren FW, Maddox FC. Stability of cefepime hydrochloride injection in polypropylene syringes at -20°C, 4°C. and 22-24°C. Am J Health-Syst Pharm 1999;56:457-9.
20. Stewart JT, Maddox FC, Warren FW. Stability of cefepime hydrochloride in polypropylene syringes (letter). Am J Health-Syst Pharm 1999; 56:1134.
21. Product information. Maxiprime (cefepime). Princeton, NJ: Bristol-Myers Squibb, 1999.